Skip to main content
Gene Therapy Net RSS feed Follow Gene Therapy Net on Twitter LinkedIn - Gene Therapy Net discussion group Facebook - Gene Therapy Net

Newsletter April 2011

Gene Therapy Net Banner
News: First Clinical Trial of Gene Therapy for Pain Shows Substantial Pain Relief for Patients
In the first clinical trial of gene therapy for treatment of intractable pain, researchers from the University of Michigan Department of Neurology observed that the treatment appears to provide substantial pain relief. In a study published online in the Annals of Neurology last week, the researchers showed that the novel agent NP2 is safe and well-tolerated. In addition, measures of pain in the treated patients suggested that NP2 may provide a substantial analgesic effect.

News: EU Clinical Trials Register goes live
Public online register gives access to information on clinical trials. The EU Clinical Trials Register ( was launched today by the European Medicines Agency (EMA). The online register gives for the first time public access to information on interventional clinical trials for medicines authorised in the 27 EU Member States and Iceland, Liechtenstein and Norway. The database also allows the public to search for information on clinical trials authorised to be carried out outside the EU if these trials are part of a paediatric investigation plan. See also Clinical Trials Databases.

News: Gene therapy a reality for Parkinson's
A groundbreaking study headquartered in Detroit has found that half the Parkinson's patients treated with gene therapy (NLX-P101) had lasting, "clinically meaningful improvements" without serious side effects, the Henry Ford Health System announced Tuesday. The study is the first time gene therapy has proven successful in Parkinson's patients and could substantially improve the lives of one million Americans with the degenerative disorder, said Dr. Peter LeWitt, director of movement disorders and lead author of the study. /span>

Conference: ImVacS - The Immunotherapeutics and Vaccine Summit, 16 – 18 August 2011
Novel Vaccines: Design & Development
Vaccine leaders from around the world will come together to discuss critical issues surrounding the development of effective – and affordable – vaccines at the 6th annual Novel Vaccines meeting. We will examine the most promising vaccines against the most pernicious diseases threatening humanity. The Novel Vaccines meeting not only provides a snapshot of where vaccine innovations stand today, but also gives vaccine professionals the opportunity to network, establish collaborations, and learn from leaders in the field.
Production & Manufacturing of Vaccines
This event brings together experts from vaccine manufacturers, suppliers, quality control, and platform development to learn new technologies, network with colleagues and advance the field of vaccine and immunotherapeutic manufacturing. With the advent of new vaccines for both infectious disease and therapeutic use, the challenge for the vaccine manufacturer is to increase productivity, maintain adherence to regulatory requirements and evaluate novel platforms and technologies to stay current. In addition to the technological advances of the field, the increased importance of both U.S. and international regulatory agencies will be addressed as well as the latest in FDA guidance documents and their impact on current production.


- 28 April 2011, 11th Workshop of the Korean Society of Gene and Cell Therapy (KSGCT) - Gene Delivery for Stem Cell Science, Catholic Institute of Science, Seoul, Korea
- 4 - 6 May 2011, Australasian Gene Therapy Society (AGTS) 7th Meeting, Melbourne, Australia
- 11 - 13 May 2011, Phacilitate’s 10th annual European Vaccine Forum & Active Immunotherapeutics Forum, Barcelona, Spain
- 18 - 21 May 2011, International Society for Cellular Therapy (ISCT) 17th Annual Meeting, Rotterdam, The Netherlands
- 18 - 22 May 2011, American Society of Gene and Cell Therapy (ASGCT) 14th Annual Meeting, Seattle, WA
- 22 – 24 May 2011, 6th International Meeting on Gene Therapy of Arthritis and Related Disorders, London, UK
- 29 May - 2 June 2011, Gordon Research Conference: Virusses & Cells, Lucca (Barga), Italy
- 6 - 8 June 2011, The 10th Annual Meeting of the French Society of Cell and Gene Therapy (SFTCG), Nantes, France
- 7 -8 June 2011, PDA Europe Workshop on Advanced Therapy Medicinal Products, Helsinki, Finland
- 12 - 14 July 2011, DNA Vaccines 2011, San Diego, LA
- 15 – 17 July 2011, The 17th Annual Meeting of the Japan Society of Gene Therapy (JSGT), Kyushu University, Fukuoka, Japan
- 16 – 18 August 2011, ImVacS: The Immunotherapeutics & Vaccine Summit, Cambridge, MA
- 19 - 21 September 2011, Phacilitate’s 1st Asian Cell & Gene Therapy Forum, Singapore
- 21 - 23 September 2011, Annual Meeting of the Spanish Society of Gene and Cell Therapy (SETGyC), Zaragoza, Spain
- 26 - 27 September 2011, ASGCT - NIH Gene Therapy Symposium, Bethesda, MD
- 27 - 31 October 2011, European Society Of Gene & Cell Therapy (ESGCT) and the British Society of Gene Therapy (BSGT) collaborative Congress 2011, Brighton, UK
- 8 November 2011, 4rd annual Workshop on Genome Engineering, Seattle, WA
- 16 - 18 November 2011, 10th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases. Focus Topic: Cell Trafficking and the Niche, Sonoma, CA


Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines. Other information websites created and maintained by the owner of Gene Therapy Net are Dengue Virus Net, Influenza Virus Net and Chikungunya Virus Net.
To unsubscribe from the Newsletter, please login and edit your subscription details or contact us. You are currently registered as: {subtag:name}, email address: {subtag:email}.

Advertise on this site?